Medytox Inc. - 16 Oct 2023 Form 4 Insider Report for Evolus, Inc. (EOLS)

Role
Former 10% Owner
Signature
/s/ Hyun Ho Jung, CEO, on behalf of Medytox Inc.
Issuer symbol
EOLS
Transactions as of
16 Oct 2023
Net transactions value
-$12,679,972
Form type
4
Filing time
18 Oct 2023, 16:21:32 UTC
Previous filing
08 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOLS Common Stock, $0.00001 par value per share Sale $12,679,972 -1,690,663 -33% $7.50 3,381,326 16 Oct 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Medytox Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.